The group’s principal activity is in the clinical research that proves disease is a 10 to 20 year progression prior to the development of symptoms and ultimately tumor growth in the form of cancer. In the year 2005, the group acquired Micro Health Systems and In the year July, 2005 Trillennium Medical Imaging, Inc. The group operates from the United States. In the year 2006, the group’s total revenue was $21,475.
